Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Issue 12, 2016
Previous Article Next Article

Synthesis of novel and potent vorapaxar analogues

Author affiliations


Vorapaxar is a first-in-class PAR-1 antagonistic drug based on the ent-himbacine scaffold. Detailed in this article are enantioselective and racemic routes to various novel vorapaxar analogues. Biological testing revealed these compounds to have moderate to excellent potencies against PAR-1 with the most potent analogue demonstrating an IC50 of 27 nM.

Graphical abstract: Synthesis of novel and potent vorapaxar analogues

Back to tab navigation

Supplementary files

Article information

11 Dec 2015
19 Feb 2016
First published
24 Feb 2016

Org. Biomol. Chem., 2016,14, 3264-3274
Article type
Author version available

Synthesis of novel and potent vorapaxar analogues

E. Knight, E. Robinson, N. Smoktunowicz, R. C. Chambers, A. E. Aliev, G. G. Inglis, V. Chudasama and S. Caddick, Org. Biomol. Chem., 2016, 14, 3264
DOI: 10.1039/C5OB02541A

Social activity

Search articles by author